Related Experiment Video
Updated: Apr 25, 2026

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
Published on: March 14, 2025
Modeling chimeric antigen receptor response at the single-cell level with conditional optimal transport
Alice Driessen1, Jannis Born2, Rocio Castellanos Rueda3
1IBM Research Europe, Zurich, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
This study introduces an optimal transport framework to predict responses to chimeric antigen receptor (CAR) T cell therapy at the single-cell level. The model accurately predicts gene expression changes and generalizes to novel CAR designs for improved cancer immunotherapy.
Area of Science:
- Immunology
- Computational Biology
- Bioinformatics
Background:
- Chimeric antigen receptor (CAR) T cell therapy shows promise for cancer treatment but faces challenges in clinical efficacy.
- Current computational models struggle to capture cellular heterogeneity and generalize to new CAR variants.
Purpose of the Study:
- To develop a computational framework for predicting CAR T cell therapy responses at the single-cell level.
- To enable the rational design of novel CARs by elucidating CAR design-function relationships.
Main Methods:
- An optimal transport (OT)-based framework was developed to predict CAR expression responses.
- Protein language models were used to embed CARs, extending the framework to a conditional OT-based model.
- The model was evaluated for its ability to capture gene expression changes and generalize to unseen CAR variants.
Main Results:
- The OT-based model accurately captures gene expression changes across diverse CAR variants.
- The model outperforms baseline methods for in-distribution CARs and reflects biological characteristics.
- The conditional OT-based model successfully generalizes predictions to out-of-distribution CAR designs.
Conclusions:
- Optimal transport-based modeling is valuable for understanding CAR design-function relationships.
- This framework facilitates the rational design of novel CARs with therapeutic potential.
- The developed model enhances the prediction of CAR T cell therapy responses.
More Related Videos
09:12Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
Published on: March 28, 2025
08:26Isolation, Cultivation, and Transient Transfection of Primary Human T Cells to Generate Chimeric Antigen Receptor (CAR) T Cells
Published on: March 27, 2026